#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medulloblastoma recurrent Progressive supranuclear palsy Vitamin B12 deficiency Craniopharyngioma Meningitis meningococcal Sarcoidosis Ductal adenocarcinoma of pancreas Liposarcoma recurrent Turner's syndrome Extra-osseous Ewing's sarcoma Deafness neurosensory Palmoplantar pustulosis Osteomyelitis Hepatitis B Hypocalcaemia More trials…

    Learn about Rare Diseases

    Chordoma – Trials in Disease Angiosarcoma Angiosarcoma metastatic – Diagnostics Waldenstrom’s macroglobulinaemia – Treatment Brain stem glioma – Treatment Atypical haemolytic uraemic syndrome Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Myelodysplastic syndrome with excess blasts Breast angiosarcoma Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naporafenib Specific Nucleic Acid Sna-Papi Maridebart Cafraglutide Diphenhydramine Hydrochloride Aaa802 Nebivolol Phenylephrine Taplucainium Chloride Almagate GSK5784283 Cln-081 Amylase Levonorgestrel Alkaline Phosphatase, Bovine Crgd-Zw800-1 T89 POLYSORBATE 80 Rbl012.2 Relebactam Mogamulizumab More therapies…

    Learn about Your Condition

    Nephropathy Pneumothorax Desmoplastic melanoma Sexual dysfunction Respiratory failure Pleural mesothelioma Laparoscopic surgery Endocarditis bacterial Notalgia paraesthetica Procedural pain Advanced systemic mastocytosis Drug eruption Meniere's disease Periodontitis Sickle cell disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute leukaemia
    • Myeloid leukaemia
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ponatinib
    Belgium France Italy The Netherlands Spain Sweden

  • Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Clofarabine
    • Cytarabine
    • Daunorubicin
    Austria Denmark Germany Italy The Netherlands Spain

  • Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

    Recruiting

    3 1 1
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Midostaurin
    • Cladribine
    Poland

  • Study on Adding Sulfasalazine, Idarubicin, and Cytarabine to Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia in Patients Aged 60 and Older

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Sulfasalazine
    • Cytarabine
    • Idarubicin Hydrochloride
    France

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Ciclosporin
    • Treosulfan
    Belgium France

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dexrazoxane
    • Gemtuzumab Ozogamicin
    • Etoposide Phosphate
    Belgium Denmark Estonia Finland Iceland Latvia +6
Previous Page
1 … 5 6 7 8 9 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!